Sixth Tone
๊ธฐํ
์ฌํ
For Congenital Deafness, a Chinese Trial Opens a Path to Sound
The worldโs first clinical trial on congenital deafness gene therapy showed that injecting a missing gene back into ear cells can restore hearing.
๐จ๐ณ ์ค๊ตญ ยท "CLINICAL" ยท ์ด 2๊ฑด
ํํฐ ๋ณด๊ธฐํ์ฌ ์ง์
50.0
0 = ๋ถ์ ์ฐ์ธ
50 = ์ค๋ฆฝ
100 = ๊ธ์ ์ฐ์ธ
์ต๊ทผ 7์ผ ๊ธฐ์ค 159๊ฑด์ ๋ถ์ํ ๊ฒฐ๊ณผ, ๋ด์ค ์ฌ๋ฆฌ์ง์๋ 50.0(๊ท ํ)์ ๋๋ค. ๊ธ์ 0๊ฑด(0.0%)ยท์ค๋ฆฝ 159๊ฑด(100.0%)ยท๋ถ์ 0๊ฑด(0.0%)์ด๋ฉฐ, ์ค๋ฆฝ ๋น์ค์ด ๋๋ ทํ๊ฒ ๋์ต๋๋ค. ์ฑํฅ ์ง์๋ ์ข ํฉ 0.0(์ค๋ ๊ท ํ)์ ๋๋ค.
The worldโs first clinical trial on congenital deafness gene therapy showed that injecting a missing gene back into ear cells can restore hearing.
China's emphasis on innovation in recent years has led to more opportunities for global clinical development and research programs to be conducted in the country, something that has benefited its people, says a leading executive at a top German pharmaceutical company.